Related Experiment Videos
Chronic aggressive hepatitis after methyldopa treatment. Case report with electron-microscopic study
Hepato-Gastroenterology
|August 1, 1981
Summary
Methyldopa can cause severe hepatitis, confirmed by drug challenge. Discontinuing methyldopa led to rapid regression of inflammation and prevented fibrogenesis, unlike other hepatitis cases.
Area of Science:
- Hepatology
- Toxicology
- Electron Microscopy
Background:
- Hepatitis is a significant concern in clinical practice.
- Drug-induced liver injury (DILI) presents diagnostic challenges.
- Methyldopa is a medication sometimes associated with adverse hepatic effects.
Observation:
- A patient developed severe, chronic, aggressive hepatitis after methyldopa use.
- Symptoms and lab findings resolved upon discontinuation of methyldopa.
- Electron microscopy revealed non-specific changes in liver cells.
Findings:
- Methyldopa-induced hepatitis showed a lack of pathological fibrogenesis.
- This absence of fibrosis is a key difference from hepatitis of unknown etiology.
- Rapid regression of severe liver damage was observed.
Implications:
- Discontinuation of methyldopa is crucial for managing drug-induced hepatitis.
- The absence of fibrosis may explain the rapid recovery observed.
- Understanding DILI mechanisms is vital for patient outcomes.